Paula Paulo

4.5k total citations
28 papers, 596 citations indexed

About

Paula Paulo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Paula Paulo has authored 28 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Paula Paulo's work include Prostate Cancer Treatment and Research (15 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer-related gene regulation (6 papers). Paula Paulo is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer-related gene regulation (6 papers). Paula Paulo collaborates with scholars based in Portugal, Norway and United States. Paula Paulo's co-authors include Manuel R. Teixeira, João D. Barros‐Silva, Rui Henrique, Ragnhild A. Lothe, Cármen Jerónimo, Rolf I. Skotheim, Franclim R. Ribeiro, Andreia Brandão, Sofia Maia and Pedro Pinto and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Paula Paulo

27 papers receiving 592 citations

Peers

Paula Paulo
Paula Paulo
Citations per year, relative to Paula Paulo Paula Paulo (= 1×) peers Gemma Toledo

Countries citing papers authored by Paula Paulo

Since Specialization
Citations

This map shows the geographic impact of Paula Paulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Paulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Paulo more than expected).

Fields of papers citing papers by Paula Paulo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Paulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Paulo. The network helps show where Paula Paulo may publish in the future.

Co-authorship network of co-authors of Paula Paulo

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Paulo. A scholar is included among the top collaborators of Paula Paulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Paulo. Paula Paulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Silva, María P., Natércia F. Brás, Lurdes Torres, et al.. (2024). BUB1B monoallelic germline variants contribute to prostate cancer predisposition by triggering chromosomal instability. Journal of Biomedical Science. 31(1). 74–74. 2 indexed citations
3.
Schacht, Caroline De, et al.. (2022). Reaching Men and Young Adults in a Pharmacy-Based HIV Self-Testing Strategy: Results from an Acceptability Study in Mozambique. AIDS Research and Human Retroviruses. 38(8). 622–630. 1 indexed citations
4.
Cardoso, Marta, Sofia Maia, Andreia Brandão, et al.. (2022). Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene. British Journal of Cancer. 128(6). 1077–1085. 6 indexed citations
5.
Gaiteiro, Cristiana, Janine Soares, Marta Relvas‐Santos, et al.. (2022). Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion. Theranostics. 12(7). 3150–3177. 29 indexed citations
6.
Peixoto, Andreia, Dylan Ferreira, Rita Azevedo, et al.. (2021). Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 191–191. 25 indexed citations
7.
Brandão, Andreia, Paula Paulo, & Manuel R. Teixeira. (2020). Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications. International Journal of Molecular Sciences. 21(14). 5036–5036. 44 indexed citations
8.
Paulo, Paula, Sofia Maia, Carla Pinto, et al.. (2018). Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer. PLoS Genetics. 14(4). e1007355–e1007355. 45 indexed citations
9.
Paulo, Paula, Pedro Pinto, Ana Peixoto, et al.. (2017). Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes. Journal of Molecular Diagnostics. 19(4). 502–513. 11 indexed citations
10.
Maia, Sofia, Marta Cardoso, Paula Paulo, et al.. (2015). The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Familial Cancer. 15(1). 111–121. 18 indexed citations
11.
Santos, Joana, João D. Barros‐Silva, Cármen Jerónimo, et al.. (2015). Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements. Oncoscience. 2(5). 497–507. 12 indexed citations
12.
Barros‐Silva, João D., Joana Santos, Rolf I. Skotheim, et al.. (2015). Specific and redundant activities ofETV1andETV4in prostate cancer aggressiveness revealed by co-overexpression cellular contexts. Oncotarget. 6(7). 5217–5236. 20 indexed citations
13.
Almeida, Mafalda, Vera L. Costa, Natália R. Costa, et al.. (2014). Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential. Journal of Cellular and Molecular Medicine. 18(11). 2287–2297. 22 indexed citations
14.
Barros‐Silva, João D., Paula Paulo, Anne Cathrine Bakken, et al.. (2013). Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer. Neoplasia. 15(7). 720–IN6. 28 indexed citations
15.
Paulo, Paula, Franclim R. Ribeiro, Joana Santos, et al.. (2012). Molecular Subtyping of Primary Prostate Cancer Reveals Specific and Shared Target Genes of Different ETS Rearrangements. Neoplasia. 14(7). 600–IN15. 58 indexed citations
16.
Paulo, Paula, Franclim R. Ribeiro, João D. Barros‐Silva, et al.. (2012). Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing’s Sarcoma and Prostate Carcinoma. PLoS ONE. 7(11). e49819–e49819. 20 indexed citations
17.
Paulo, Paula, João D. Barros‐Silva, Franclim R. Ribeiro, et al.. (2011). FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Genes Chromosomes and Cancer. 51(3). 240–249. 64 indexed citations
18.
Ribeiro, Franclim R., Paula Paulo, Vera L. Costa, et al.. (2011). Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene. PLoS ONE. 6(7). e22317–e22317. 36 indexed citations
19.
Costa, Natália R., Paula Paulo, Thomas C. Caffrey, Michael A. Hollingsworth, & Filipe Santos‐Silva. (2011). Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line. PLoS ONE. 6(11). e26970–e26970. 17 indexed citations
20.
Barros, Rita, Bruno Pereira, Isabelle Duluc, et al.. (2008). Key elements of the BMP/SMAD pathway co‐localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. The Journal of Pathology. 215(4). 411–420. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026